Avalon GloboCare (AVCO) to Change Ticker to ALBT Nov 9, 2022 04:00PM
Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT” Nov 9, 2022 04:00PM
Avalon GloboCare (AVCO) to acquire a 60% interest in Laboratory Services MSO Nov 8, 2022 09:11AM
Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million Nov 8, 2022 09:10AM
Avalon Globocare to Present at the LD Micro Main Event XV on October 26th Oct 19, 2022 09:00AM
View Older Stories

Sep 29, 2022 09:05AM Avalon GloboCare (AVCO) Receives Allowance for Joint U.S. Patent
Sep 29, 2022 09:00AM Avalon GloboCare Receives Allowance for Joint U.S. Patent
Aug 8, 2022 09:01AM Avalon GloboCare (AVCO) Reports Publication Featuring QTY Code Technology
Aug 8, 2022 09:00AM Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society
Aug 8, 2022 09:00AM Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society
Jun 30, 2022 09:00AM Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer
Jun 30, 2022 09:00AM Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer
May 25, 2022 09:00AM Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference
May 25, 2022 09:00AM Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference
May 18, 2022 09:00AM Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy
May 18, 2022 09:00AM Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy
Apr 27, 2022 09:03AM Avalon GloboCare (AVCO) Files 16 New Patent Applications
Apr 27, 2022 09:00AM Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications
Apr 27, 2022 09:00AM Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications
Feb 14, 2022 09:12AM Avalon GloboCare (AVCO) Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer Cell Therapies
Feb 14, 2022 09:00AM Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
Feb 14, 2022 09:00AM Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
Jan 4, 2022 09:06AM Avalon GloboCare (AVCO) Provides Year-End Business Update of Selective Scientific and Clinical Programs
Jan 4, 2022 09:00AM Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
Jan 4, 2022 09:00AM Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
Dec 22, 2021 09:03AM Avalon GloboCare's (AVCO) Chairman Converts $3M of Debt into Common Stock $1.25/sh
Dec 22, 2021 09:00AM Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
Dec 22, 2021 09:00AM Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
Dec 9, 2021 09:00AM Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development
Dec 9, 2021 09:00AM Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development
Oct 14, 2021 09:21AM Avalon GloboCare (AVCO) Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
Oct 14, 2021 09:20AM Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
Oct 14, 2021 09:20AM Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
Oct 7, 2021 09:00AM Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for
Oct 7, 2021 09:00AM Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for
Sep 23, 2021 09:00AM Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th
Sep 23, 2021 09:00AM Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th
Aug 4, 2021 09:00AM UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare
Aug 4, 2021 09:00AM UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare
Jul 1, 2021 09:00AM Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain Cancer
Jul 1, 2021 09:00AM Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain Cancer
Jun 28, 2021 09:07AM Avalon GloboCare (AVCO) CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio
Jun 28, 2021 09:04AM Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio
Jun 28, 2021 09:04AM Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio
Jun 14, 2021 09:00AM Avalon GloboCare (AVCO) Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
Jun 14, 2021 09:00AM Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
Jun 14, 2021 09:00AM Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
Jun 11, 2021 09:00AM Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021
Jun 11, 2021 09:00AM Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021
Jun 8, 2021 09:00AM Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit
Jun 8, 2021 09:00AM Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit
Mar 29, 2021 09:28AM Avalon GloboCare (AVCO) Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR P
Mar 29, 2021 09:25AM Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ Plat
Mar 29, 2021 09:25AM Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ Plat
Mar 22, 2021 09:00AM Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis
View Older Stories